Effect of fibrinolysis on the empyema cavity size after VATS and open surgery. Effect of fibrinolysis on the empyema cavity size after VATS and open surgery.

Slides:

Advertisements

Similar presentations

Patients who had reported experiencing symptoms in the previous 7 days were asked during what times of the day the symptoms were most troublesome. a) Breathlessness,

Advertisements

Measured values of a) inspiratory volume, b) PEEP, c) FIO2 and d) respiratory rate delivered to a test lung by several devices in four intensive care units.

Axial magnetic resonance (MR) imaging

Dried blood spot for therapeutic drug monitoring. a).

Rigid instruments for medical thoracoscopy: a) trocar and cannula with valve; b) single-incision thoracoscope (9-mm diameter); c) biopsy forceps with straight.

Computed tomography simulation of medical thoracoscopy with rigid instruments (right thoracic cavity in left lateral position). Computed tomography simulation.

The values for the provoking dose of mannitol to cause a 15% decrease (PD15) in forced expiratory volume in 1 s (FEV1) showing the different levels of.

Decision tree of the FALLS protocol.

Bland–Altman comparison of lung clearance index (LCI) from multiple breath wash-out following open and modified closed circuit wash-in for both healthy.

Effects of reslizumab on asthma quality of life questionnaire (AQLQ) score in Global Initiative for Asthma (GINA) Step 4 and 5 patients. Effects of reslizumab.

Effect of treatment with bronchial thermoplasty at different temperature on airway responsiveness to methacholine (MCh) and airway pathology in dogs. a)

Decision tree of the BLUE protocol.

The effect of sequential addition of sildenafil to first-line epoprostenol on exercise capacity measured using 6-min walk distance (6MWD) in the PACES.

Chest radiograph suggestive of pneumomediastinum (air outlining the mediastinal structures) and subcutaneous emphysema in the area of the left axilla,

A) Peak forced expiratory volume in 1 s within 3 h post-dosing (peak FEV10–3h) response following once-daily tiotropium Respimat add-on to medium-dose.

Predicted values for a, b) FEV1, c, d) FVC and e, f) FEV1/FVC by sex and ethnic group. a, c, e) Males and b, d, f) females. Predicted values for a, b)

A) Coronal reconstruction of chest CT angiography images showing marked hypodensity of the left upper lobe. b) Coronal reconstruction of maximum intensity.

Integrated research framework, bounded by population and ecology of care axes running from highly selected to managed care populations (Y-axis) and from.

Swimmer plots showing post-nivolumab progression-free survival for the three main drugs studied according to the line of treatment in which they were received.

Risk of bias summary for Cochrane review comparing pMDI and spacer to nebulisers to deliver β2-agonists to adults and children with acute asthma. Risk.

Level of physical activity by Global Initiative for Obstructive Lung Disease (GOLD) stage, BODE (body mass index, FEV1 for airflow obstruction, dyspnoea,

VATS decortication in pleural empyema stage II

Forest plot showing the number of adults (at the top) and children (lower down) who were admitted to hospital after treatment in the emergency department.

Treatment algorithm for managing chronic thromboembolic pulmonary hypertension (CTEPH), from the European Society of Cardiology/European Respiratory Society.

Simplified model of cardiorespiratory control showing coupling between respiratory and cardiovascular systems. τ: circulatory delay; ILV: instantaneous.

Kaplan–Meier analysis of survival over 2 years of treatment with riociguat in the CHEST-2 study [54]. Kaplan–Meier analysis of survival over 2 years of.

Representative diaphragm electromyogram (EMG) tracings at rest (a and b) and during maximum voluntary ventilation (c and d) in a healthy subject (a and.

Axial CT scans of the chest. a) Before treatment

The events that lead to airway narrowing and a reduction in forced expiratory volume in 1 s in response to different indirect challenge tests. The events.

Association between cardiovascular disease, cardiovascular risk factors and chronic obstructive pulmonary disease (COPD) on mortality. Association between.

Reducing antibiotic use in influenza: challenges and rewards

Prevalence of chronic bronchitis in relation to active smoking, stratified by age. □: nonsmokers; ▒: 1–10 cigarettes per day; ░: 11–20 cigarettes per day;

Relationship between exercise mPAP and cardiac output.

3-year survival of lung cancer patients in the general population and in those with a prior diagnosis of chronic obstructive pulmonary disease (COPD).

A family-based pulmonary rehabilitation (PR) programme enhanced the coping resources of the families of chronic obstructive pulmonary disease patients.

Evaluation of cognitive performance based on the ability to copy a simple drawing. Evaluation of cognitive performance based on the ability to copy a simple.

A) Total Asthma Quality of Life Questionnaire (AQLQ) score over 12 months after treatment with bronchial thermoplasty (BT) in the per protocol population.

A)Standardised mortality ratios for chronic bronchitis in men and women (1968–1978) and b) infant mortality from bronchitis and pneumonia per 1000 births.

Post-bronchodilator forced expiratory volume in 1 s (FEV1) to forced vital capacity (FVC) ratio in subjects aged >50 yrs. Post-bronchodilator forced expiratory.

The changing distribution of endothelin (ET)A and ETB subtypes with decreasing vessel diameter. a) ET-1 binding and b) distribution of ETA and ETB receptors.

Nonexpandable lung. a) A single-use digital pleural manometer for use during thoracentesis. b) Pleural elastance curves representing normal, entrapped.

Severe exacerbations and emergency department (ED) visits in the 5 years after bronchial thermoplasty (BT). a) Proportion of subjects with severe exacerbations.

Comparison between prediction equations from Wang et al

Proportion of patients in each World Health Organization functional class (WHO-FC) at the time of pulmonary arterial hypertension-associated systemic sclerosis.

Apoptosis of bronchial epithelial cells in post-race samples

Distribution of mutations in sporadic and familial pulmonary arterial hypertension (PAH) and pulmonary veno-occlusive disease and/or pulmonary capillary.

Exposure to intermittent hypoxia after 13 nights led to an increase in sympathetic activity measured by muscle sympathetic nerve activity (MSNA). Exposure.

Follow-up contrast-enhanced computed tomography (CT); case one, obtained 19 days after presentation. a) Axial CT of the neck at the level of the hyoid.

Post-operative a) neutrophil counts, but not b) lymphocyte or c) platelet counts, were higher in current smokers than ex-smokers. #: time-points were statistically.

The linear decrease in TLCO as the accessible VA decreases is associated with an exponential increase in KCO. For instance, TLCO decreases ∼25% while KCO.

Bland–Altman comparison of functional residual capacity (FRC) measured from multiple breath wash-out following open and modified closed circuit wash-in.

Effect of omalizumab (n = 209) on a) clinically significant and b) severe exacerbation rates, compared with placebo (n = 210). #: adjustment due to a pre-study.

Lung function adjusted for body length and gestational age in male and female premature infants. Lung function adjusted for body length and gestational.

Correlation between inspiratory capacity (IC)/total lung capacity (TLC) ratio and oxygen pulse at peak exercise in chronic obstructive pulmonary disease.

Adjusted mean±se response in peak forced expiratory volume in 1 s within 3 h post-dosing (peak FEV10–3h) at week 24, following once-daily tiotropium Respimat.

The European population from 1950 to 2050, with estimated population before 2006 (light background) and projected population (dark background). The European.

Risk ratio (RR) and number needed to treat (NNT) are time-dependent measures. a) When an intervention is associated with constant relative risk reduction.

The gas/tissue ratio, an index of alveolar inflation in normal lung (n=14), supine (□) and prone (○) position, and lung of acute respiratory distress syndrome.

Bench test setting for automatic continuous positive airway pressure (APAP) devices. a) System to simulate the breathing pattern and airway obstructions.

A) Operating lung volumes and b) breathing frequency (Fb) during incremental cycle exercise in patients with moderate chronic obstructive pulmonary disease.

24-h blood pressure profile after a, d) one night of intermittent hypoxia (IH) exposure, b, e) 13 nights IH exposure and c, f) 5 days after cessation of.

Interventional bronchoscopic and surgical treatments for chronic obstructive pulmonary disease (COPD). Interventional bronchoscopic and surgical treatments.

Mean change from baseline in percentage predicted forced vital capacity (FVC) in the a) phase III CAPACITY [27] and b) ASCEND [14] studies. #: n=174; ¶:

A) Reported tuberculosis cases in Sweden by country of birth, 1984–1996. b) Reported tuberculosis cases in Denmark by country of birth. ○: born abroad;

A) The World Health Organization (WHO) model of resource allocation in cancer care from 1990 depicting “present allocation of cancer resources” and “proposed.

Baseline New York Heart Association functional class (NYHA FC) predicts survival in patients with pulmonary hypertension using infused epoprostenol therapy.

Flow–volume loops of test breaths and preceding control breaths of a representative chronic obstructive pulmonary disease patient with different degrees.

Flow–volume loops of test breaths and preceding control breaths of three representative chronic obstructive pulmonary disease patients with different degrees.

Correlation between leg fluid volume (LFV) displacement measured by electrical impedance and apnoea/hypopnoea index (AHI) in non-obese obstructive sleep.

Effect of placebo (n=88) and bosentan (n=80) on the co-primary end-point pulmonary vascular resistance (PVR) in the EARLY (Endothelial Antagonist Trial.

Presentation transcript:

Effect of fibrinolysis on the empyema cavity size after VATS and open surgery. Effect of fibrinolysis on the empyema cavity size after VATS and open surgery. A: initial cavity size reduction by VATS debridement alone; B: initial cavity size reduction by open decortication; C1: additional post-operative cavity size reduction by fibrinolysis during the first 40 post-operative days after VATS debridement; C2: additional effect of fibrinolysis during 100 post-operative days after the open surgery. Reproduced and modified from [26] with permission. Dragan Subotic et al. Breathe 2018;14:302-310 ©2018 by European Respiratory Society